Quintana to appeal Tour de France disqualification at CAS / Photo: Marco BERTORELLO - AFP/File
NYSE - LSE
| CMSC | -0.18% | 24.52 | $ | |
| RBGPF | -0.91% | 59.65 | $ | |
| BCE | -0.68% | 27.126 | $ | |
| SCS | -0.23% | 13.06 | $ | |
| JRI | -0.53% | 13.19 | $ | |
| GSK | -0.42% | 33.321 | $ | |
| RIO | 0.11% | 62.5 | $ | |
| AZN | -0.65% | 63.385 | $ | |
| BCC | -0.13% | 137.995 | $ | |
| NGG | -0.55% | 63.23 | $ | |
| RYCEF | -1.98% | 6.56 | $ | |
| RELX | -0.8% | 44.93 | $ | |
| VOD | 0.22% | 8.94 | $ | |
| BTI | 0.15% | 36.985 | $ | |
| CMSD | -0.34% | 24.26 | $ | |
| BP | -0.38% | 28.981 | $ |
Quintana to appeal Tour de France disqualification at CAS
Nairo Quintana has lodged an appeal against his Tour de France disqualification for taking a banned pain medication with the Court of Arbitration for Sport, the tribunal announced Thursday.
The Colombian was stripped of his sixth-place finish for taking tramadol, a synthetic opioid which has been on a list of cycling's prohibited substances since 2019.
"At this time, it is not possible to indicate when the final decision will be announced," the court said in a statement.
A panel of arbitrators must be appointed before the date for a hearing can be set.
Traces of tramadol and its two main metabolites were found in two dried blood samples provided by Quintana on July 8 and 13 during the Tour, the International Cycling Union (UCI) said last month.
As a first-time offender, he was not banned from further competition and had been free to compete in the Vuelta a Espana.
However, the 32-year-old withdrew from the race the day before it started, saying he did not have "the head or the body for competition".
Quintana was the first Colombian to win a Grand Tour when he claimed Giro d'Italia glory in 2014. He triumphed in the Vuelta two years later.
J.Faber--LiLuX
